Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells-Reference-Cited by-同舟云学术

Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells

Published:2018-01-03 Issue:6 Volume:9 Page:6883-6896
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hsu Sanford P.C.¹²,Kuo John S.³,Chiang Hsin-Chien⁴,Wang Hsin-Ell⁵,Wang Yu-Shan⁴,Huang Cheng-Chung⁴,Huang Yi-Chun⁴,Chi Mau-Shin⁶,Mehta Minesh P.⁷,Chi Kwan-Hwa⁵⁷

Affiliation:

1. Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan

2. School of Medicine, National Yang Ming University, Taipei, Taiwan

3. Department of Neurological Surgery, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA

4. JohnPro Biotech Inc., Taipei, Taiwan

5. Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan

6. Department of Radiation Therapy and Oncology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan

7. Miami Cancer Institute, Miami, FL, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood-brain barrier penetrating nanosystems enable synergistic therapy of glioblastoma;Nano Today;2024-06

2. Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues;International Journal of Molecular Sciences;2023-11-14

3. Real-Time Monitoring of Lysosomal Membrane Permeabilization Using Acridine Orange;Methods and Protocols;2023-08-09

4. Cholesterol Metabolism in Cancer and Cell Death;Antioxidants & Redox Signaling;2023-07-01

5. Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy;Anti-Cancer Agents in Medicinal Chemistry;2023-06